Global and China Erythropoietin (EPO) Drugs Market Size, Status and Forecast 2020-2026

September 2020 | 95 pages | ID: GB4CBE8E3414EN
QYResearch

Abstracts

Global Erythropoietin (EPO) Drugs Scope and Market Size
Erythropoietin (EPO) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erythropoietin (EPO) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• Epoetin-alfa
• Darbepoetin-alfa

Market segment by Application, split into

• Hospitals
• Homecare
• Specialty Clinics
• Others

Based on regional and country-level analysis, the Erythropoietin (EPO) Drugs market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Erythropoietin (EPO) Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Pfizer
• Roche
• Amgen
• Johnson & Johnson
• Kyowa Kirin
• Shanghai Dahua Pharmaceutical
• JCR Pharmaceuticals
• Teva Pharmaceuticals

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Epoetin-alfa
  1.2.3 Darbepoetin-alfa
1.3 Market by Application
  1.3.1 Global Erythropoietin (EPO) Drugs Market Share by Application: 2020 VS 2026
  1.3.2 Hospitals
  1.3.3 Homecare
  1.3.4 Specialty Clinics
  1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Erythropoietin (EPO) Drugs Market Perspective (2015-2026)
2.2 Global Erythropoietin (EPO) Drugs Growth Trends by Regions
  2.2.1 Erythropoietin (EPO) Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Erythropoietin (EPO) Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Erythropoietin (EPO) Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Erythropoietin (EPO) Drugs Players by Market Size
  3.1.1 Global Top Erythropoietin (EPO) Drugs Players by Revenue (2015-2020)
  3.1.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Erythropoietin (EPO) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Erythropoietin (EPO) Drugs Revenue
3.4 Global Erythropoietin (EPO) Drugs Market Concentration Ratio
  3.4.1 Global Erythropoietin (EPO) Drugs Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Erythropoietin (EPO) Drugs Revenue in 2019
3.5 Key Players Erythropoietin (EPO) Drugs Area Served
3.6 Key Players Erythropoietin (EPO) Drugs Product Solution and Service
3.7 Date of Enter into Erythropoietin (EPO) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ERYTHROPOIETIN (EPO) DRUGS BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Erythropoietin (EPO) Drugs Historic Market Size by Type (2015-2020)
4.2 Global Erythropoietin (EPO) Drugs Forecasted Market Size by Type (2021-2026)

5 ERYTHROPOIETIN (EPO) DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Erythropoietin (EPO) Drugs Historic Market Size by Application (2015-2020)
5.2 Global Erythropoietin (EPO) Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Erythropoietin (EPO) Drugs Market Size (2015-2026)
6.2 North America Erythropoietin (EPO) Drugs Market Size by Type (2015-2020)
6.3 North America Erythropoietin (EPO) Drugs Market Size by Application (2015-2020)
6.4 North America Erythropoietin (EPO) Drugs Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Erythropoietin (EPO) Drugs Market Size (2015-2026)
7.2 Europe Erythropoietin (EPO) Drugs Market Size by Type (2015-2020)
7.3 Europe Erythropoietin (EPO) Drugs Market Size by Application (2015-2020)
7.4 Europe Erythropoietin (EPO) Drugs Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Erythropoietin (EPO) Drugs Market Size (2015-2026)
8.2 China Erythropoietin (EPO) Drugs Market Size by Type (2015-2020)
8.3 China Erythropoietin (EPO) Drugs Market Size by Application (2015-2020)
8.4 China Erythropoietin (EPO) Drugs Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Erythropoietin (EPO) Drugs Market Size (2015-2026)
9.2 Japan Erythropoietin (EPO) Drugs Market Size by Type (2015-2020)
9.3 Japan Erythropoietin (EPO) Drugs Market Size by Application (2015-2020)
9.4 Japan Erythropoietin (EPO) Drugs Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Erythropoietin (EPO) Drugs Market Size (2015-2026)
10.2 Southeast Asia Erythropoietin (EPO) Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Erythropoietin (EPO) Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Erythropoietin (EPO) Drugs Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11KEY PLAYERS PROFILES

11.1 Pfizer
  11.1.1 Pfizer Company Details
  11.1.2 Pfizer Business Overview
  11.1.3 Pfizer Erythropoietin (EPO) Drugs Introduction
  11.1.4 Pfizer Revenue in Erythropoietin (EPO) Drugs Business (2015-2020))
  11.1.5 Pfizer Recent Development
11.2 Roche
  11.2.1 Roche Company Details
  11.2.2 Roche Business Overview
  11.2.3 Roche Erythropoietin (EPO) Drugs Introduction
  11.2.4 Roche Revenue in Erythropoietin (EPO) Drugs Business (2015-2020)
  11.2.5 Roche Recent Development
11.3 Amgen
  11.3.1 Amgen Company Details
  11.3.2 Amgen Business Overview
  11.3.3 Amgen Erythropoietin (EPO) Drugs Introduction
  11.3.4 Amgen Revenue in Erythropoietin (EPO) Drugs Business (2015-2020)
  11.3.5 Amgen Recent Development
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Details
  11.4.2 Johnson & Johnson Business Overview
  11.4.3 Johnson & Johnson Erythropoietin (EPO) Drugs Introduction
  11.4.4 Johnson & Johnson Revenue in Erythropoietin (EPO) Drugs Business (2015-2020)
  11.4.5 Johnson & Johnson Recent Development
11.5 Kyowa Kirin
  11.5.1 Kyowa Kirin Company Details
  11.5.2 Kyowa Kirin Business Overview
  11.5.3 Kyowa Kirin Erythropoietin (EPO) Drugs Introduction
  11.5.4 Kyowa Kirin Revenue in Erythropoietin (EPO) Drugs Business (2015-2020)
  11.5.5 Kyowa Kirin Recent Development
11.6 Shanghai Dahua Pharmaceutical
  11.6.1 Shanghai Dahua Pharmaceutical Company Details
  11.6.2 Shanghai Dahua Pharmaceutical Business Overview
  11.6.3 Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Introduction
  11.6.4 Shanghai Dahua Pharmaceutical Revenue in Erythropoietin (EPO) Drugs Business (2015-2020)
  11.6.5 Shanghai Dahua Pharmaceutical Recent Development
11.7 JCR Pharmaceuticals
  11.7.1 JCR Pharmaceuticals Company Details
  11.7.2 JCR Pharmaceuticals Business Overview
  11.7.3 JCR Pharmaceuticals Erythropoietin (EPO) Drugs Introduction
  11.7.4 JCR Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2015-2020)
  11.7.5 JCR Pharmaceuticals Recent Development
11.8 Teva Pharmaceuticals
  11.8.1 Teva Pharmaceuticals Company Details
  11.8.2 Teva Pharmaceuticals Business Overview
  11.8.3 Teva Pharmaceuticals Erythropoietin (EPO) Drugs Introduction
  11.8.4 Teva Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2015-2020)
  11.8.5 Teva Pharmaceuticals Recent Development

12ANALYST'S VIEWPOINTS/CONCLUSIONS

13APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Epoetin-alfa
Table 4. Key Players of Darbepoetin-alfa
Table 5. Global Erythropoietin (EPO) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Erythropoietin (EPO) Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Erythropoietin (EPO) Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Erythropoietin (EPO) Drugs Market Share by Regions (2015-2020)
Table 9. Global Erythropoietin (EPO) Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Erythropoietin (EPO) Drugs Market Share by Regions (2021-2026)
Table 11. Erythropoietin (EPO) Drugs Market Market Trends
Table 12. Erythropoietin (EPO) Drugs Market Drivers
Table 13. Erythropoietin (EPO) Drugs Market Challenges
Table 14. Erythropoietin (EPO) Drugs Market Restraints
Table 15. Global Erythropoietin (EPO) Drugs Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Erythropoietin (EPO) Drugs Market Share by Players (2015-2020)
Table 17. Global Top Erythropoietin (EPO) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin (EPO) Drugs as of 2019)
Table 18. Global Erythropoietin (EPO) Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Erythropoietin (EPO) Drugs Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Erythropoietin (EPO) Drugs Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Erythropoietin (EPO) Drugs Market Size Share by Type (2015-2020)
Table 24. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2021-2026)
Table 25. Global Erythropoietin (EPO) Drugs Market Size Share by Application (2015-2020)
Table 26. Global Erythropoietin (EPO) Drugs Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Erythropoietin (EPO) Drugs Market Size Share by Application (2021-2026)
Table 28. North America Erythropoietin (EPO) Drugs Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Erythropoietin (EPO) Drugs Market Share by Type (2015-2020)
Table 30. North America Erythropoietin (EPO) Drugs Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Erythropoietin (EPO) Drugs Market Share by Application (2015-2020)
Table 32. North America Erythropoietin (EPO) Drugs Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Erythropoietin (EPO) Drugs Market Share by Country (2015-2020)
Table 34. Europe Erythropoietin (EPO) Drugs Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Erythropoietin (EPO) Drugs Market Share by Type (2015-2020)
Table 36. Europe Erythropoietin (EPO) Drugs Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Erythropoietin (EPO) Drugs Market Share by Application (2015-2020)
Table 38. Europe Erythropoietin (EPO) Drugs Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Erythropoietin (EPO) Drugs Market Share by Country (2015-2020)
Table 40. China Erythropoietin (EPO) Drugs Market Size by Type (2015-2020) (US$ Million)
Table 41. China Erythropoietin (EPO) Drugs Market Share by Type (2015-2020)
Table 42. China Erythropoietin (EPO) Drugs Market Size by Application (2015-2020) (US$ Million)
Table 43. China Erythropoietin (EPO) Drugs Market Share by Application (2015-2020)
Table 44. China Erythropoietin (EPO) Drugs Market Size by Region (US$ Million) (2015-2020)
Table 45. China Erythropoietin (EPO) Drugs Market Share by Region (2015-2020)
Table 46. Japan Erythropoietin (EPO) Drugs Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Erythropoietin (EPO) Drugs Market Share by Type (2015-2020)
Table 48. Japan Erythropoietin (EPO) Drugs Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Erythropoietin (EPO) Drugs Market Share by Application (2015-2020)
Table 50. Japan Erythropoietin (EPO) Drugs Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Erythropoietin (EPO) Drugs Market Share by Country (2015-2020)
Table 52. Southeast Asia Erythropoietin (EPO) Drugs Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Erythropoietin (EPO) Drugs Market Share by Type (2015-2020)
Table 54. Southeast Asia Erythropoietin (EPO) Drugs Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Erythropoietin (EPO) Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Erythropoietin (EPO) Drugs Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Erythropoietin (EPO) Drugs Market Share by Country (2015-2020)
Table 58. Pfizer Company Details
Table 59. Pfizer Business Overview
Table 60. Pfizer Product
Table 61. Pfizer Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Product
Table 66. Roche Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 67. Roche Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Product
Table 71. Amgen Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 72. Amgen Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Product
Table 76. Johnson & Johnson Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. Kyowa Kirin Company Details
Table 79. Kyowa Kirin Business Overview
Table 80. Kyowa Kirin Product
Table 81. Kyowa Kirin Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 82. Kyowa Kirin Recent Development
Table 83. Shanghai Dahua Pharmaceutical Company Details
Table 84. Shanghai Dahua Pharmaceutical Business Overview
Table 85. Shanghai Dahua Pharmaceutical Product
Table 86. Shanghai Dahua Pharmaceutical Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 87. Shanghai Dahua Pharmaceutical Recent Development
Table 88. JCR Pharmaceuticals Company Details
Table 89. JCR Pharmaceuticals Business Overview
Table 90. JCR Pharmaceuticals Product
Table 91. JCR Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 92. JCR Pharmaceuticals Recent Development
Table 93. Teva Pharmaceuticals Business Overview
Table 94. Teva Pharmaceuticals Product
Table 95. Teva Pharmaceuticals Company Details
Table 96. Teva Pharmaceuticals Revenue in Erythropoietin (EPO) Drugs Business (2015-2020) (US$ Million)
Table 97. Teva Pharmaceuticals Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Erythropoietin (EPO) Drugs Market Share by Type: 2020 VS 2026
Figure 2. Epoetin-alfa Features
Figure 3. Darbepoetin-alfa Features
Figure 4. Global Erythropoietin (EPO) Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Homecare Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Erythropoietin (EPO) Drugs Report Years Considered
Figure 10. Global Erythropoietin (EPO) Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Erythropoietin (EPO) Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Erythropoietin (EPO) Drugs Market Share by Regions (2021-2026)
Figure 13. Global Erythropoietin (EPO) Drugs Market Share by Players in 2019
Figure 14. Global Top Erythropoietin (EPO) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin (EPO) Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Erythropoietin (EPO) Drugs Revenue in 2019
Figure 16. North America Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Erythropoietin (EPO) Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Pfizer Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 44. Roche Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 45. Amgen Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 46. Johnson & Johnson Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 47. Kyowa Kirin Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 48. Shanghai Dahua Pharmaceutical Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 49. JCR Pharmaceuticals Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 50. Teva Pharmaceuticals Revenue Growth Rate in Erythropoietin (EPO) Drugs Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed